ETFs Holding PGNX »    PGNX Historical Stock Prices »
PGNX News Video: Thu, Mar 30, 2017, 12:24 PM — Thursday's ETF Movers: KRE, XBI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Progenics Pharmaceuticals develop medicines and other technologies to target and treat cancer. Co.'s clinical-stage product candidates in oncology include, among others: AZEDRA, a radiotherapeutic product candidate in development as a treatment for malignant and/or recurrent pheochromocytoma and paraganglioma, rare tumors found in the adrenal glands and outside of the adrenal glands, respectively; 1404, a technetium small molecule which binds PSMA and is used as an imaging agent to diagnose and detect localized prostate cancer as well as soft tissue and bone metastases; and PyL, a clinical-stage, fluorinated PSMA-targeted Positron Emission Topography imaging agent for prostate cancer. Self directed investors in Progenics Pharmaceuticals, Inc. will be interested in keeping up with all Progenics Pharmaceuticals, Inc. news they can find, both PGNX news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on PGNX. At RediNews, we simplify this task by presenting both PGNX news releases originating from Progenics Pharmaceuticals, Inc. itself, and PGNX news from a variety of media outlets. Visitors can browse this news online and through our PGNX RSS news feed.


PGNX News — Articles, Videos, & Press Releases

Analysts Anticipate 15% Gains Ahead For EWSC
Monday, April 29, 2019, 8:16 AM — ETF Channel
Add Up The Parts: SLYG Could Be Worth $67
Thursday, March 28, 2019, 8:23 AM — ETF Channel
Interesting PGNX Put And Call Options For November 15th
Wednesday, March 20, 2019, 10:38 AM — Stock Options Channel
Implied EWSC Analyst Target Price: $64
Monday, February 25, 2019, 7:59 AM — ETF Channel
First Week of March 15th Options Trading For Progenics Pharmaceuticals
Thursday, January 24, 2019, 11:15 AM — Stock Options Channel
Analysts Expect SPMD To Hit $37
Monday, January 21, 2019, 8:41 AM — ETF Channel
Interesting PGNX Put And Call Options For August 16th
Thursday, January 3, 2019, 11:37 AM — Stock Options Channel
Commit To Buy Progenics Pharmaceuticals At $3, Earn 16.7% Using Options
Wednesday, December 26, 2018, 11:24 AM — Stock Options Channel
Analysts See 30% Upside For The Holdings of IJR
Thursday, December 20, 2018, 7:56 AM — ETF Channel
Sum Up The Pieces: IJR Could Be Worth $91
Monday, November 19, 2018, 7:37 AM — ETF Channel
Investors Grab PGNX 35.6% Lower Than Its Secondary Stock Offering
Wednesday, November 7, 2018, 10:19 AM — Dividend Channel
Progenics Pharmaceuticals Becomes Oversold (PGNX)
Wednesday, October 17, 2018, 11:53 AM — Dividend Channel
Short Interest In Progenics Pharmaceuticals Drops 16.7%
Wednesday, September 26, 2018, 12:00 PM — Market News Video
First Week of May 2019 Options Trading For Progenics Pharmaceuticals (PGNX)
Wednesday, September 26, 2018, 11:14 AM — Stock Options Channel
Interesting PGNX Put And Call Options For January 2021
Tuesday, September 18, 2018, 11:08 AM — Stock Options Channel
Noteworthy Monday Option Activity: PCYG, CWH, PGNX
Monday, September 17, 2018, 3:44 PM — Stock Options Channel
How The Pieces Add Up: XBI Headed For $138
Monday, September 17, 2018, 7:50 AM — ETF Channel
RSI Alert: Progenics Pharmaceuticals (PGNX) Now Oversold
Thursday, September 13, 2018, 12:19 PM — Dividend Channel
Notable Two Hundred Day Moving Average Cross - PGNX
Monday, September 10, 2018, 4:42 PM — Market News Video
Progenics Pharmaceuticals Stock Sees Short Interest Decline 12%
Monday, August 27, 2018, 11:33 AM — Market News Video
First Week of October 19th Options Trading For Progenics Pharmaceuticals (PGNX)
Tuesday, August 21, 2018, 11:04 AM — Stock Options Channel
Investors Land PGNX Even Lower Than Its Secondary Stock Offering
Thursday, August 9, 2018, 10:06 AM — Dividend Channel
The Implied Analyst 12-Month Target For ESML
Thursday, August 9, 2018, 9:34 AM — ETF Channel
Notable Tuesday Option Activity: MRNS, PGNX, MB
Tuesday, July 31, 2018, 3:17 PM — Stock Options Channel
Relative Strength Alert For Progenics Pharmaceuticals
Tuesday, July 24, 2018, 4:23 PM — Dividend Channel
First Week of PGNX September 21st Options Trading
Tuesday, July 24, 2018, 12:29 PM — Stock Options Channel
Progenics Pharmaceuticals Stock Sees Short Interest Increase 12.7%
Thursday, July 12, 2018, 10:30 AM — Market News Video
Implied XBI Analyst Target Price: $136
Friday, June 29, 2018, 7:38 AM — ETF Channel
First Week of February 2019 Options Trading For Progenics Pharmaceuticals (PGNX)
Wednesday, June 20, 2018, 11:39 AM — Stock Options Channel
Noteworthy Monday Option Activity: WTW, CORT, PGNX
Monday, June 18, 2018, 3:22 PM — Stock Options Channel
Notable Thursday Option Activity: ASH, PGNX, ACC
Thursday, May 24, 2018, 3:17 PM — Stock Options Channel
We Did The Math XBI Can Go To $127
Wednesday, May 23, 2018, 12:05 PM — ETF Channel
First Week of PGNX July 20th Options Trading
Wednesday, May 23, 2018, 10:38 AM — Stock Options Channel
PGNX is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

FVE News

Suppose you have experience with web publishing content and are starting a new financial website. You will have a stock index table with every major stock index you can think of, at the top you have the current market time and whether the markets are open or closed, and then you have a quote box where users can enter symbols to get a detailed quote like you would see on an investor relations quote page, along with historical stock quote information either in a stock table or stock market chart graphics. As you design your site, you may have a stock template created once and used for each possible stock ticker symbol, and you may have a stock price panel along the right-hand or left-hand column of other pages of your site. You've got mainly all your basis covered in terms of data, securing a stock market content provider for licensed quote content and historical stock data. But what about news? The same investor relations services providers that provide investor relations content can provide press releases but none of these investor relations tools contain third party articles. While third party articles can sometimes be critical of companies, that's what you want when looking for financial portal content, because corporate relations content designed for investor relations quotes pages is concerned with eliminating negativity and controversy. But third party news articles are critical for websites whose readers want to read all the news about the stocks they own, both published by the company and published by third parties. It is for this reason that RSS feeds by RediNews can add a compelling piece of additional dynamic content to your website. Look for the RSS icon on any news page within RediNews (which will look like this): to access our free RSS-based news feeds to supplement your web content.

PGNX News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.